Abstract:
The study showed clear evidence that HBV was being transmitted at an alarming rate among
cancer patient on chemotherapy especially patients with acute lymphoblastic leukemia. It
was also suggestive that HCV was being transmitted too. The screening procedure for blood
given to cancer patients is obviously inadequate and it is recommended that such blood
should be screened for HBV by RIA. Testing of surrogate markers (anti-HBc and serum
alanine amino transferees) is recommended to reduce the risk of HVC transmission. Initial
and periodic testing of cancer patient for HBV makers (HBsAg and anti-HBc) is
recommended. Also the strict adherence to universal precautions at the cancer hospital
Maharagama
